iSpecimen Inc (ISPC) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak financial performance, no positive trading signals, and lacks any significant catalysts or positive sentiment. The technical indicators are bearish, and there is no recent news or analyst support to suggest a turnaround. Given these factors, it is advisable to avoid this stock at the moment.

Technical Analysis

The technical indicators for ISPC are bearish. The MACD histogram is negative and contracting, RSI is neutral at 42.391, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 0.296, with support at 0.242 and resistance at 0.349.

Positive Catalysts

NULL identified. There is no recent news, no significant trading trends, and no positive sentiment from hedge funds or insiders.

Neutral/Negative Catalysts

The company's financials are weak, with a -96% YoY drop in revenue, a -77.14% YoY drop in EPS, and a gross margin decline of -321.27% YoY. Additionally, there is no recent news or trading activity to suggest a positive turnaround.

Financial Performance

In Q3 2025, the company's revenue dropped significantly by -96% YoY to $106,592. Net income improved slightly but remains negative at -$2,780,648, up 93.12% YoY. EPS dropped by -77.14% YoY to -0.48, and gross margin fell drastically to -92.05%, down -321.27% YoY. Overall, the financial performance is poor.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast ISPC stock price to rise

Buy

Hold

Sell

Current: 0.250

Low

Averages

High